Generic Drugmakers Struggle Despite Us Push For Copycats | Latest News RSS feed

Generic Drugmakers Struggle Despite Us Push For Copycats - Latest News


Generic Drugmakers Struggle Despite U.S. Push for Copycats

Generic drugmakers are being crushed ... Just four of the 12 approved biologic copycat drugs are actually being sold, according to the generic-drug industry group the Association for Affordable ... read more

Generic drugmakers struggle to stay afloat

Many drugmakers have decried ... Just four of the 12 approved biologic copycat drugs are actually being sold, according to the generic-drug industry group the Association for Affordable Medicines, ... read more

Generic drugmakers feel pinch as prices crumble

An aggravating factor has been greater supply from Indian makers of generic drugs, which have increased their share of the US market despite nagging ... been lucrative for generic drugmakers. The ... read more

Looking for another news?


Ranbaxy scrambles for ingredients to make generic Nexium

For Ranbaxy, any deal to buy in ingredients will push up costs and reduce profits ... ANDA refers to Abbreviated New Drug Application, which generic drugmakers file with the FDA to seek approval for ... read more


Plans to slash medical costs in US run into generic drug concerns

Washington: As US regulators push hundreds of new generic drugs to market in an effort to drive down prices, the industry is facing a continuing problem in India, where many copycat medicines ... ... read more

Generic Drugmakers Get Boost as FDA Move Helps Complex Copycats

Read more: Generic drugmakers struggle despite U.S. push for copycats There are only a few birth-control patches on the market, including CombiPatch, and more than 182,000 prescriptions were written ... read more

Amgen Wins Reprieve on Its 2nd-Best-Selling Drug

That may mean it's only a matter of time before generic drug companies, including Mylan (NASDAQ:MYL), win FDA approval of biosimilar copycats ... to the tune of about $12 million per day. Despite ... read more

Generic Drugmakers Struggle Despite U.S. Push for Copycats

(Bloomberg) -- Generic drugmakers are being ... four of the 12 approved biologic copycat drugs are actually being sold, according to the generic-drug industry group the Association for Affordable ... read more

Analysis: Roche stays a step ahead of copycat drugmakers

Generic copies, therefore, are more difficult to develop and market. While rival drugmakers ... Roche to push back to early 2016 the date it expects the first MabThera biosimilar, meaning that sales ... read more

Ranbaxy scrambles for ingredients to make generic Nexium

Nexium had global sales last year of $3.87 billion and US sales of $2.12 billion ... ANDA refers to Abbreviated New Drug Application, which generic drugmakers file with the FDA to seek approval for ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us